Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM)
USD 25.94
(0.14%)
USD 25.94
(0.14%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 183.17 Million USD | 75.83% |
| 2022 | 104.17 Million USD | 45.38% |
| 2021 | 71.65 Million USD | 478.88% |
| 2020 | 12.37 Million USD | 1.3% |
| 2019 | 12.21 Million USD | 1.83% |
| 2018 | 11.99 Million USD | -14.34% |
| 2017 | 14 Million USD | 76.49% |
| 2016 | 7.93 Million USD | -4.79% |
| 2015 | 8.33 Million USD | 43773.68% |
| 2014 | 19 Thousand USD | 0.0% |
| 2013 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 184.14 Million USD | 0.53% |
| 2024 Q2 | 185.02 Million USD | 0.48% |
| 2023 Q2 | 169.71 Million USD | 0.51% |
| 2023 Q1 | 168.85 Million USD | 62.08% |
| 2023 Q4 | 183.17 Million USD | 0.54% |
| 2023 Q3 | 182.18 Million USD | 7.35% |
| 2023 FY | 183.17 Million USD | 75.83% |
| 2022 Q2 | 72.04 Million USD | 0.27% |
| 2022 Q4 | 104.17 Million USD | 44.21% |
| 2022 FY | 104.17 Million USD | 45.38% |
| 2022 Q1 | 71.84 Million USD | 0.27% |
| 2022 Q3 | 72.23 Million USD | 0.27% |
| 2021 Q2 | 71.26 Million USD | 548.1% |
| 2021 Q1 | 10.99 Million USD | -42.27% |
| 2021 Q3 | 71.45 Million USD | 0.27% |
| 2021 FY | 71.65 Million USD | 478.88% |
| 2021 Q4 | 71.65 Million USD | 0.28% |
| 2020 Q3 | 19.96 Million USD | -1.07% |
| 2020 FY | 12.37 Million USD | 1.3% |
| 2020 Q4 | 19.04 Million USD | -4.57% |
| 2020 Q1 | 17.84 Million USD | -3.99% |
| 2020 Q2 | 20.17 Million USD | 13.08% |
| 2019 Q4 | 18.58 Million USD | -0.85% |
| 2019 Q3 | 18.74 Million USD | -3.9% |
| 2019 Q2 | 19.5 Million USD | 11.66% |
| 2019 Q1 | 17.46 Million USD | 45.56% |
| 2019 FY | 12.21 Million USD | 1.83% |
| 2018 FY | 11.99 Million USD | -14.34% |
| 2018 Q4 | 11.99 Million USD | -5.28% |
| 2018 Q1 | 14.41 Million USD | -2.15% |
| 2018 Q2 | 13.63 Million USD | -5.38% |
| 2018 Q3 | 12.66 Million USD | -7.11% |
| 2017 FY | 14 Million USD | 76.49% |
| 2017 Q1 | 7.19 Million USD | -22.72% |
| 2017 Q3 | 14.76 Million USD | 14.54% |
| 2017 Q4 | 14.72 Million USD | -0.22% |
| 2017 Q2 | 12.88 Million USD | 79.17% |
| 2016 Q4 | 9.3 Million USD | -17.44% |
| 2016 FY | 7.93 Million USD | -4.79% |
| 2016 Q3 | 11.27 Million USD | 17.81% |
| 2016 Q2 | 9.56 Million USD | 2.84% |
| 2016 Q1 | 9.3 Million USD | 8.26% |
| 2015 Q1 | 415 Thousand USD | 2084.21% |
| 2015 FY | 8.33 Million USD | 43773.68% |
| 2015 Q4 | 8.59 Million USD | 0.83% |
| 2015 Q3 | 8.52 Million USD | 1.19% |
| 2015 Q2 | 8.42 Million USD | 1929.88% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | 25.09 Thousand USD | 146.77% |
| 2014 Q4 | 19 Thousand USD | -24.28% |
| 2014 Q2 | 10.16 Thousand USD | 0.0% |
| 2014 FY | 19 Thousand USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 19.93 Thousand USD | -918700.161% |
| BIMI International Medical Inc. | 2.88 Million USD | -6239.147% |
| China Jo-Jo Drugstores, Inc. | 6.4 Million USD | -2760.338% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 183.17 Million USD | 0.0% |
| Leafly Holdings, Inc. | 29.08 Million USD | -529.782% |
| Leafly Holdings, Inc. | 29.08 Million USD | -529.782% |
| LifeMD, Inc. | 17.92 Million USD | -921.725% |
| LifeMD, Inc. | 17.92 Million USD | -921.725% |
| TRxADE HEALTH, Inc. | 434.2 Thousand USD | -42085.604% |
| PetMed Express, Inc. | 995 Thousand USD | -18309.246% |
| Walgreens Boots Alliance, Inc. | 8.04 Billion USD | 97.723% |